Selective phosphorylation of PKA targets after β-adrenergic receptor stimulation impairs myofilament function in

Aref Najafi1, Vasco Sequeira2, Michiel Helmes2

  • 1Department of Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center Amsterdam, Netherlands ICIN-Netherlands Heart Institute, Utrecht, The Netherlands a.najafi@vumc.nl.

Cardiovascular Research
|January 31, 2016
PubMed

Insights

In hypertrophic cardiomyopathy (HCM), beta-adrenergic receptor (β-AR) signaling affects protein kinase A (PKA) targets differently. PKA preferentially phosphorylates phospholamban over cardiac troponin I in HCM mice, impairing heart function.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetic Diseases

Background:

  • Hypertrophic cardiomyopathy (HCM) is linked to reduced beta-adrenergic receptor (β-AR) signaling and impaired protein kinase A (PKA) phosphorylation.
  • The specific impact of diminished β-AR signaling on various PKA targets in HCM remains unclear.

Purpose of the Study:

  • To investigate the role of β-AR signaling in regulating myofilament and calcium handling in a Mybpc3-mutation-induced HCM mouse model.
  • To determine if PKA targets are affected uniformly by reduced β-AR signaling in HCM.

Main Methods:

  • Cardiomyocyte contractile properties and phosphorylation were analyzed in wild-type, heterozygous (HET), and homozygous (KI) Mybpc3-targeted knock-in mice.
  • Measurements included myofilament calcium sensitivity, passive tension, and responses to isoprenaline (ISO) in permeabilized and intact cardiomyocytes.

Main Results:

  • Homozygous KI mice exhibited increased myofilament calcium sensitivity and passive tension, normalized by PKA treatment.
  • Impaired force-sarcomere length relationships were observed in HET and KI mice, indicating reduced length-dependent activation.
  • While calcium handling responded to ISO, myofilament contraction did not in KI mice, linked to reduced cardiac troponin I (cTnI) phosphorylation but maintained phospholamban (PLN) phosphorylation.

Conclusions:

  • In the KI HCM mouse model, β-AR stimulation results in preferential PKA phosphorylation of phospholamban (PLN) over cardiac troponin I (cTnI).
  • This selective phosphorylation pattern contributes to impaired inotropic and lusitropic responses in HCM.
  • Findings highlight differential regulation of PKA targets in response to β-AR signaling in HCM.
Abstract